Call Us      +44 (0)20 70961222

Clinical Operations

JOIN OUR USA EAST COAST 2018 STRATEGY MEETING


6th November 2018 | The Westin Boston Waterfront

OUR UNIQUE FORMAT

The Clinical Operations Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Clinical Operations (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities.

Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– Clinical Operations, Data Sciences, Clinical Outsourcing, Patient Recruitment, eTMF, Safety Data Management, Clinical Trial Management, Data Acquisition Technology and Integrations, Clinical, Pharmacology Scientific Operations, Clinical Informatics and Innovation.

KEY OPINION LEADERS
Ran Frenkel

Ran Frenkel

Chief Development and Operations Officer

Karyopharm Therapeutics Inc.

Michael Meyers

Michael Meyers

Chief Medical Officer

Syndax Phamaceuticals

Eyal Ron

Eyal Ron

Chief Technology Officer

Gelesis

Ana Sharma

Ana Sharma

Global Head, Strategy and Operations, Clinical Development Quality

Novartis

Heather Dibenedetto

Heather Dibenedetto

Vice President, Therapeutics Operations

Moderna Therapeutics

Murray Abramson

Murray Abramson

Vice President, Global Clinical Operations

Biogen Idec

Charlotte French

Charlotte French

Executive Director Outsourcing & Contracts, Medical and Development

Astellas

Marie-Christine Poisson-Carvajal

Marie-Christine Poisson-Carvajal

Director Head of TMF Operations

Pfizer

WHAT TO EXPECT
roundtable
Interactive Roundtable Discussions

Attendees can proactively share and ask questions to their peers about the success of their work in an informal setting.

one to one copy
Director level one-to-one meetings

We provide opportunities to engage with one another in our strategy meeting in a series of pre-arranged business meetings by interacting face to face.

agenda
Tailor-fit and Personalized Agenda

Being able to experience different sessions is what makes our event unique that’s why our attendees can personalize and select sessions they want to participate in.

netwkorking copy
Networking Opportunities

Several networking opportunities are in store for attendees to connect and build new relationships with their peers through luncheons, cocktails and informal introductions.

Thank you for reaching Proventa International

One of our executives will contact you within 24 hours

CLINICAL OPERATIONS

STRATEGY MEETING USA EAST COAST 2018








***The information you provided in this website is confidential and the company will strictly forbidden to share any part of these information with any third party without a written consent of the sender.

BECOME SPONSOR

If you are an exciting start-up trying to get your innovation in front global heads from the leading Pharmaceutical companies, or a mature market-leading conglomerate with legacy solutions trying to stay one step ahead of the competition – we are here to help!

WHAT PEOPLE SAY

Clinical Operations Strategy Meeting US 2017

John Apathy, Vice President, R&D informatics, Celgene

Lars Branden, Senor Director,Informatics R&D Division, Retro Screen Virology Ltd.

Dominic Clark , Industry Programme Manager, EMBL-EBI

Yike Guo, Director Data Science Institude, Imperial College London

John Wise, Executive Director, Pistoia Alliance

Abel Ureta-Vida, CEO, Eagle Genomics

Alexander Scheer, Deputy Head of Research, Pierre Fabre

Jerome Wojcik , CEO, Quartz Bio

Oleksandr Otava, Head Of Scientific IT, Affiris AG

Sowmyanarayan Srinivasan, Director R&D Practise,Global Delivery Leader Discovery

Clinical Data Strategy Meeting Europe 2015

Matthew Plaud

Chief Executive Officer

Its very constructive, my experience is a variety of events that I'll always got the most views out of interactions and being able to challenge each one another.

Neil Gordan

Director MRL Logistics

You really getting to know each other. Very nice mixed in gaining different perspective into it. I want to participate in meeting again because you can have open and share discussions, you were working with others and dealing with the same challenges.

Steven Jacobs

President, Global Biopherm Solutions

It is a really good one, it gives an opportunity to leads and share what they know, asked questions before they can walk away in that meeting.

Rob Murphy

Executive Director, Global Clinical Supply Chain

The rountable discussions format helps me learn, getting to know them and learn challenges that they'll have. It keeps me awake and energized, So I like it! and its works for me.

Images coming soon

THE VENUE

THE WESTIN
BOSTON WATERFRONT


Address

425 Summer St, Boston, MA 02210, USA


Phone

+1 617-532-4600

OUR MEDIA PARTNERS




Robert-Gut-270×260

Robert Gut

Chief Medical Officer, Versartis

Anthony-Maida

Anthony Maida

Senior Vice President Clinical Research, Northwest Biotherapeutics

Lyssa-Friedman

Lyssa Friedman

Vice President Clinical and Regulatory Affairs, OncoCyte Corporation

Mary-Rose-Keller-270×260

Mary Rose Keller

Vice President Clinical Operations, Heron Therapeutics

Farah-Anwar

Farah Anwar

Vice President Clinical Operations,

Juno Therapeutics

Robert-Gut-270×260

Laura Ishak

Vice President Clinical Operations, Blaze BioScience

Michael-Rosenblatt

Michael Rosenblatt

Global Head, Clinical Operations Systems and
Process Excellence, Genentech

Michael is the Global Head of Systems and Process Excellence for late stage Clinical Operations (PDG) at Roche and a member of the Clinical Operations leadership team. He is accountable for supporting infrastructure, tools, processes, and systems enabling the operation of Roche’s clinical trials globally, across multiple study phases. He sits on several committees overseeing, systems, data, and infrastructure projects across Roche’s late stage portfolio operations. Previous to his role in Clinical Operations, Mr. Rosenblatt was the Global Head of Regulatory Technology for late stage . Prior to joining Roche, Mr. Rosenblatt was a life sciences consultant for IBM. He has also held numerous consulting, sales, marketing, and operational roles for several other US-based enterprises.

Maria-Koutsopoulou

Maria Koutsopoulou

Global Head, Regional Clinical Operations, Merck